Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

Innowage

Status: Completed

Conditions: Hayfever; Allergic Rhinitis; Allergy Pollen

Treatments: Dietary Supplement: Hayfever Care; Other: Wait-list Control

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT06765239

InnUK/MN/0120

Details and patient eligibility

About

This waitlist-controlled trial aims to evaluate the therapeutic effectiveness of Hayfever Care by assessing disease-specific symptoms over a 4-week period. Additionally, the study examines the tolerability and safety of the solution.

Enrollment: 63 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Mild to moderate symptoms during the hayfever season
• Generally healthy individuals without chronic illnesses
• Willingness to comply with study requirements, including completing symptom diaries.

Exclusion criteria

• History of anaphylaxis or severe hayfever symptoms requiring emergency treatment.
• Pregnant or breastfeeding
• History of substance abuse or excessive alcohol consumption.
• Use of systemic corticosteroids, immunotherapy

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

63 participants in 2 patient groups

Hayfever Care

Experimental group

Description:

Hayfever Care, a powdered natural food supplement.

Treatment:

Dietary Supplement: Hayfever Care

Wait-list Care

Other group

Description:

No supplement was given during the trial period

Treatment:

Other: Wait-list Control